General Report Contents
• Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
• Market Drivers & Limiters for each chapter segment
• Competitive Analysis for each chapter segment
• Section on recent mergers & acquisitions
Stereotaxy has become the standard of care in neurosurgery and is now used in the majority of cranial cases. This has led to market saturation; however, there will still be some growth in unit sales as facilities that did not want to share multi-application platforms between hospital departments purchase additional units.
The market has been increasingly transitioning to the use of frameless stereotactic systems which can be used for pre-surgical planning as well as guidance through most cranial procedures. These devices incorporate superior technology and updated features.
However, frame-based systems remain the golden standard in terms of accuracy and are more commonly used for small targets and procedures like the implantation of deep brain stimulators. This benefit will allow them to maintain their share of the market until frameless technology reaches the same level of accuracy.
'
TABLE OF CONTENTS I
LIST OF FIGURES X
LIST OF CHARTS XII
EXECUTIVE SUMMARY 1
EUROPEAN NEUROMODULATION, NEUROVASCULAR, NEUROSURGICAL AND MONITORING DEVICE MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 3
MARKET TRENDS 7
MARKET DEVELOPMENTS 10
MARKETS INCLUDED 11
PROCEDURES INCLUDED 12
KEY REPORT UPDATES 13
VERSION HISTORY 13
RESEARCH METHODOLOGY 14
1.1 RESEARCH SCOPE 14
1.2 IDATA’S 9-STEP METHODOLOGY 14
Step 1: Project Initiation & Team Selection 14
Step 2: Prepare Data Systems and Perform Secondary Research 16
Step 3: Preparation for Interviews & Questionnaire Design 17
Step 4: Performing Primary Research 18
Step 5: Research Analysis: Establishing Baseline Estimates 20
Step 6: Market Forecast and Analysis 21
Step 7: Identify Strategic Opportunities 23
Step 8: Final Review and Market Release 24
Step 9: Customer Feedback and Market Monitoring 25
DISEASE OVERVIEW 26
2.1 BASIC ANATOMY 26
2.2 DISEASE PATHOLOGY AND DISORDERS 28
2.2.1 Introduction 28
2.2.2 General Diagnostics and Neurosurgery 30
2.2.3 Tumor and Brain Cancer 32
2.2.4 Brain Arteriovenous Malformations 34
2.2.5 Ischemic Stroke 35
2.2.6 Brain Aneurysm 36
2.2.7 Disorders Related to Cerebrospinal Fluids and Intracranial Pressure 38
2.2.7.1 Hydrocephalus and Intracranial Pressure Disorder 38
2.2.7.2 Cerebral Edema 39
2.2.8 Indication for Neuromodulation 41
2.2.9 Traumatic brain injury 43
COUNTRY PROFILES 44
3.1 INTRODUCTION 44
3.1.1 Population 44
3.1.2 GDP Per Capita 44
3.1.3 Price Index 44
3.2 GERMANY 45
3.3 FRANCE 46
3.4 UNITED KINGDOM 47
3.5 ITALY 48
3.6 SPAIN 49
3.7 BENELUX 50
3.8 SCANDINAVIA 51
3.9 AUSTRIA 52
3.10 SWITZERLAND 53
3.11 PORTUGAL 54
PRODUCT ASSESSMENT 55
4.1 PRODUCT PORTFOLIOS 55
4.1.1 Stereotactic Devices 55
4.1.1.1 Introduction 55
4.1.1.2 Product Matrix for Stereotactic Devices: Core Companies 57
4.2 REGULATORY ISSUES AND RECALLS 58
4.2.1 Stereotactic Devices 58
4.3 CLINICAL TRIALS 61
4.3.1 Stereotactic Devices 61
STEREOTACTIC MARKET 62
5.1 INTRODUCTION 62
5.2 MARKET OVERVIEW 64
5.3 MARKET ANALYSIS AND FORECAST 68
5.3.1 Frame-Based Stereotactic Market 68
5.3.2 Frameless Stereotactic Market 75
5.4 INSTALLED BASE ANALYSIS 82
5.4.1 Frame-Based Stereotactic Market 82
5.4.2 Frameless Stereotactic Market 83
5.5 DRIVERS AND LIMITERS 84
5.5.1 Market Drivers 84
5.5.2 Market Limiters 85
5.6 COMPETITIVE MARKET SHARE ANALYSIS 87
ABBREVIATIONS 94
APPENDIX: COMPANY PRESS RELEASES 97
Chart 1 1: Neurological Device Market by Segment, Europe, 2013 – 2023 2
Chart 1 2: Neurological Device Market Overview, Europe, 2013 &2023 2
Chart 3 1: Country Profile, Germany, 2016 45
Chart 3 2: Country Profile, France, 2016 46
Chart 3 3: Country Profile, United Kingdom, 2016 47
Chart 3 4: Country Profile, Italy, 2016 48
Chart 3 5: Country Profile, Spain, 2016 49
Chart 3 6: Country Profile, Benelux, 2016 50
Chart 3 7: Country Profile, Scandinavia, 2016 51
Chart 3 8: Country Profile, Austria, 2016 52
Chart 3 9: Country Profile, Switzerland, 2016 53
Chart 3 10: Country Profile, Portugal, 2016 54
Chart 5 1: Stereotactic Market by Segment, Europe, 2013 – 2023 66
Chart 5 2: Stereotactic Market Breakdown, Europe, 2016 67
Chart 5 3: Stereotactic Market Breakdown, Europe, 2023 67
Chart 5 4: Frame-Based Stereotactic Market, Europe, 2013 – 2023 69
Chart 5 5: Frameless Stereotactic Market, Europe, 2013 – 2023 76
Chart 5 6: Leading Competitors, Stereotactic Market, Europe, 2016 91
Figure 1 1: Neurological Device Market Share Ranking by Segment, Europe, 2016 (1 of 3) 4
Figure 1 2: Neurological Device Market Share Ranking by Segment, Europe, 2016 (2 of 3) 4
Figure 1 3: Neurological Device Market Share Ranking by Segment, Europe, 2016 (3 of 3) 5
Figure 1 4: Companies Researched in this Report, Europe, 2016 6
Figure 1 5: Factors Impacting the Neurological Device Market by Segment, Europe (1 of 3) 7
Figure 1 6: Factors Impacting the Neurological Device Market by Segment, Europe (2 of 3) 8
Figure 1 7: Factors Impacting the Neurological Device Market by Segment, Europe (3 of 3) 9
Figure 1 8: Recent Events in the Neurological Device Market, Europe, 2014 – 2016 10
Figure 1 9: Neurological Device Markets Covered, Europe, 2016 11
Figure 1 10: Neurological Device Procedures Covered, Europe, 2016 12
Figure 1 11: Key Report Updates 13
Figure 1 12: Version History 13
Figure 2 1: Neurology Disease Overview 29
Figure 2 2: Brain/Other Nervous System Cancer Statistics by Type and Gender, U.S., 2016 33
Figure 4 1: Class 2 Device Recall: StealthStation System, Medtronic Navigation, Inc. 58
Figure 4 2: Class 2 Device Recall: Leksell Gamma Knife Perfexion and Leksell Gamma Knife Icon, Elekta, Inc 58
Figure 4 3: Class 2 Device Recall: Brainlab Cranial Navigation System, Brainlab AG 59
Figure 4 4: Class 2 Device Recall: Brainlab AG 59
Figure 4 5: Class 2 Device Recall: Brainlab 59
Figure 4 6: Class 2 Device Recall: Stereotactic Circular Collimator 3D Line stereotactic Hardware Accessories 60
Figure 4 7: Class 2 Device Recall: 43410 FRAMELESS SRS QA TARGET POINTER 60
Figure 4 8: Class 2 Device Recall: Integra XKnife Stereotactic Radiosurgery and Radiotherapy Treatment Planning 60
Figure 4 9: Class 2 Device Recall: CRW Precision Arc (CRWPRECISE), CRW Arc System (CRWASL) 60
Figure 4 10: Stereotactic Device: Panobinostat and Stereotactic Radiation Therapy in Treating Patients With Brain Tumors 61
Figure 4 11: Stereotactic Device: Protocol for Staged Stereotactic Radiosurgery for Large Arteriovenous Malformations 61
Figure 5 1: Stereotactic Market by Segment, Europe, 2013 – 2023 (€M) 65
Figure 5 2: Stereotactic Market by Segment, Europe, 2013 – 2023 (US$M) 65
Figure 5 3: Frame-Based Stereotactic Market, Europe, 2013 – 2023 (€ and US$) 68
Figure 5 4: Units Sold by Country, Frame-Based Stereotactic Market, Europe, 2013 – 2023 70
Figure 5 5: Average Selling Price by Country, Frame-Based Stereotactic Market, Europe, 2013 – 2023 (€) 71
Figure 5 6: Average Selling Price by Country, Frame-Based Stereotactic Market, Europe, 2013 – 2023 (US$) 72
Figure 5 7: Market Value by Country, Frame-Based Stereotactic Market, Europe, 2013 – 2023 (€M) 73
Figure 5 8: Market Value by Country, Frame-Based Stereotactic Market, Europe, 2013 – 2023 (US$M) 74
Figure 5 9: Frameless Stereotactic Market, Europe, 2013 – 2023 (€ and US$) 75
Figure 5 10: Units Sold by Country, Frameless Stereotactic Market, Europe, 2013 – 2023 77
Figure 5 11: Average Selling Price by Country, Frameless Stereotactic Market, Europe, 2013 – 2023 (€) 78
Figure 5 12: Average Selling Price by Country, Frameless Stereotactic Market, Europe, 2013 – 2023 (US$) 79
Figure 5 13: Market Value by Country, Frameless Stereotactic Market, Europe, 2013 – 2023 (€M) 80
Figure 5 14: Market Value by Country, Frameless Stereotactic Market, Europe, 2013 – 2023 (US$M) 81
Figure 5 15: Installed Base, Frame-Based Stereotactic Market, Europe, 2013 – 2023 82
Figure 5 16: Installed Base, Frameless Stereotactic Market, Europe, 2013 – 2023 83
Figure 5 17: Drivers and Limiters, Stereotactic Market, Europe, 2016 86
Figure 5 18: Leading Competitors, Stereotactic Market, Europe, 2016 91
Figure 5 19: Leading Competitors by Country, Frame-Based Stereotactic Market, Europe, 2016 92
Figure 5 20: Leading Competitors by Country, Frameless Stereotactic Market, Europe, 2016 93
Figure 7 1: Press Release Summary 97
Medtronic
Stryker
Codman & Shurtleff, Inc.
St. Jude Medical
Nevro
Carl Zeiss
Boston Scientific
LivaNova
Terumo MicroVention
Penumbra Inc.
Leica
Integra LifeSciences
BrainLab
Balt
Magstim
Phenox
MagVenture
Elekta
Moëller Wedel
Misonix
Sophysa
Aesculap
MAG & More
Neurosoft
Acandis
Soring
Brainsway
Nexstim
Others include: ANT, Asahi Intecc, Axonics, Blockade, Dispomedica, Enteromedics, Flowonix, Inomed, Intrapace, Kaneka Medical Products, MHT, Micrus Endovascular, MRC, Navimetric, Neuravi, Neuronetics, Neuropace, NextGen Medicla System, Nuvectra, Scientia Vascular, Spiegelberg, Stimwave, Tokai Medical Product, Tricumed, Vascular Solutions, etc.
